Skip to main content

AD progresses in recent 10 years: from hypothesis to therapeutic targets

Guested edited by Weihong Song (Jining Medical University)

A thematic series in Translational Neurodegeneration. 

  1. Alzheimer’s disease (AD) is a progressive neurodegenerative disease with phenotypic changes closely associated with both genetic variants and imaging pathology. Brain imaging biomarker genomics has been develo...

    Authors: Lanlan Li, Xianfeng Yu, Can Sheng, Xueyan Jiang, Qi Zhang, Ying Han and Jiehui Jiang
    Citation: Translational Neurodegeneration 2022 11:42
    Content type: Review Published on:

  2. Alzheimer’s disease (AD) is the most common neurodegenerative disease in the elderly worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the understanding of this disease, and may b...

    Authors: Chenghuan Song, Jiyun Shi, Pingao Zhang, Yongfang Zhang, Jianrong Xu, Lanxue Zhao, Rui Zhang, Hao Wang and Hongzhuan Chen
    Citation: Translational Neurodegeneration 2022 11:18
    Content type: Review Published on:

  3. Synaptic abnormalities are a cardinal feature of Alzheimer’s disease (AD) that are known to arise as the disease progresses. A growing body of evidence suggests that pathological alterations to neuronal circui...

    Authors: Lina Gao, Yun Zhang, Keenan Sterling and Weihong Song
    Citation: Translational Neurodegeneration 2022 11:4
    Content type: Review Published on: